doi: 10.2147/DMSO.S271160 [DOI] [PMC free article] [PubMed] [Google Scholar] 91.Hsieh CF, Liu CK, Lee CT, Yu LE, Wang JY
GLP-1 acts by stimulating glucose-dependent insulin release from the pancreatic islets, which in turn slows down gastric emptying and supresses appetite
A deficiency in vitamin B12 has been linked to depression and other mood disorders
GLP-1 stimulates glucose-dependent insulin secretion by pancreatic cells, inhibits glucagon secretion, and regulates postprandial glycemia, as well as cytoprotective and anti-inflammatory activities on cells [16,17,18]
In weight management, semaglutide is approved for people who have a body mass index (BMI) of 30 or higher or a BMI of 27 or higher with weight-related health conditions like high blood pressure or type 2 diabetes